Article info
PDFReview
Clinical management of immune-related adverse events following immunotherapy treatment in patients with non-small cell lung cancer
- Correspondence to Dr Jorge Nieva, University of Southern California - Norris Comprehensive Cancer Center and Hospital, Los Angeles, CA 90033, USA; Jorge.Nieva{at}med.usc.edu
Citation
Clinical management of immune-related adverse events following immunotherapy treatment in patients with non-small cell lung cancer
Publication history
- Accepted April 27, 2021
- First published June 14, 2021.
Online issue publication
September 27, 2021
Article Versions
- Previous version (14 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Federation for Medical Research 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.